Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss is a rare but recognized symptom of pemphigus vulgaris, with patients usually regrowing hair after treatment.

The document concludes that it's important to recognize and treat hair loss in women of color, considering their unique hair characteristics and psychological impact.

Over one-third of women experience hair loss, with female-pattern hair loss being most common, and treatments include minoxidil and possibly hair transplantation.

Women with hair loss may benefit from higher iron levels.

Spironolactone is effective for treating female hair loss, with new treatments like clascoterone showing promise.

Activated PRP effectively increases hair density and reduces hair loss in alopecia.

Black women's unique hair characteristics and styling practices can lead to specific scalp conditions, which require early diagnosis and appropriate treatment.

Regenerative cellular therapies show promise for treating non-scarring hair loss but need more research.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.

Most cases of Temporal Triangular Alopecia are found in early childhood and may be related to genetic conditions.

Hair loss in women often doesn't follow a pattern, isn't linked to age, may be genetic, and can be related to thyroid issues or other health factors.

Moderately high prolactin levels do not cause hair loss in women.

Women with PCOS in North China often have hirsutism and acne, with hirsutism linked to metabolic issues.

Early treatment helps stop hair loss in women of color.

ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.

Asian women with breast cancer experience the highest rates of long-term hair loss and related distress after chemotherapy.

Trichoscopy is reliable for diagnosing different types of frontal non-scarring hair loss.

More effective methods are needed to prevent hair loss from chemotherapy.

Early intervention and patient education are crucial for managing alopecia areata.

Alopecia areata causes sudden hair loss, has genetic links, and can be managed but not cured.

Up to 50% of women may experience significant hair loss by age 50, with various causes and treatments available.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Obese women with PCOS are more likely to have fatty liver disease.

Finasteride 5 mg/day effectively treats hair loss in postmenopausal women without hyper-androgenism.

Various potential triggers may be causing the rise in frontal fibrosing alopecia, and avoiding these could help stop the disease's increase.

Testosterone implants in women require pharmacological dosing to be effective and are generally safe and well-tolerated.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

ViviScal®, a food supplement, was found to be highly effective in treating hereditary hair loss in young males, while fish extract showed no impact.

RU58841 significantly increases hair growth rate and initiates more hair cycles, but doesn't affect hair thickness, suggesting it could be a new treatment for baldness.

A woman developed rare, unexplained curly hair on her scalp and eyelashes.